chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2 days p/vax pt devel lt facial numbness & tingling as well as it progressed later to lt side of body lasted approx 2-4mo initially;fatigue also;
unconsolable high pitch crying for 4-5 hrs; shorley p/last vax @ 2mos of age 7AUG92;
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 01/10/21Moderna,Lot#025J2OA 2nd dose: 02/07/21Pfizer,Lot# 013L20A Diagnosed covid positive:08/11/21 Symptom onset:08/09/21 Exposure:Community Symptoms:fever, cough,fatigue,loss of smell/taste, sore throat, runny nose, headache.
PATIENT'S RIGHT ARM WITH HEPATITIS AND SHRINGRIX VACCINE WAS TENDER, SORE, RED AND WARM TO THE TOUCH  FOR NEXT FEW DAYS, ISN'T GETTING WORSE
Ringing in my ears after second Moderna shot 5/4/2021. Had Covid in November and did not have ringing in my ears. This is brand new and while I had other reactions such as chills and aches after each shot this ringing has remained. Very concerning.
Three days after the shot, my right arm's shoulder bone is protruding with a dip in my shoulder to the right side.  It does not hurt, but aches a little now and then.  When looking at me from the front, my right shoulder droops to the outside.
Extreme body soreness; body felt heavy like I couldn't move; headaches all day; lethargy; loss of taste persisting all day; This is a spontaneous report from a contactable consumer (patient). A 27-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number: ER8731) via an unspecified route, administered in left arm on 28May2021 at 15:45 (age at vaccination: 27 years) as dose 2, single for covid-19 immunisation at workplace clinic. Patient was not pregnant at the time of vaccination. The patients medical history included undifferentiated connective tissue disease (auto immune condition that is suspected lupus at last rheumatology visit). raynauds, chronic fatique. There were non known allergies. List of any other medications the patient received within 2 weeks of vaccination included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), alprazolam (XANAX), hydroxychloroquine, paracetamol (TYLENOL). The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number: ER8731) via an unspecified route, administered in left arm on 07May2021 at 13:00 (age at vaccination was 27 years) as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown that prior to vaccination, the patient was diagnosed with COVID-19 and unknown for covid prior vaccination. On 29May2021 at 04:00, the patient experienced extreme body soreness, body felt heavy like she could not move, headaches all day, lethargy, loss of taste persisting all day. She did not receive treatment for adverse events. Since the vaccination, she was not tested covid post vaccination. The outcome of events not recovered.   Follow-up attempts were completed. No further information was expected.
Administration of expired dose; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of expired dose) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of expired dose). On 01-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Administration of expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The  concomitant medications on use were not provided. No treatment information was provided.
Intermittent fevers (up to 103.1); inflamed asthma symptoms; bronchitis; chills; brain fog; vertigo; This is a spontaneous report from a contactable consumer (patient). This 64-year-old female patient received the 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Er8730) via an unspecified route of administration in the left arm on 02Apr2021 15: 15 as single dose for COVID-19 immunization. Medical history included allergy induced asthma and hypothyroid. Concomitant medications included levothyroxine, simvastatin, omeprazole. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced 4 weeks of intermittent fevers (up to 103.1), chills and inflamed asthma symptoms including bronchitis and brain fog. Then, week 5 just as the patient was beginning to feel better, vertigo. All stated on 03Apr2021 21:00. Treatment was received for the adverse event with steroids, antibiotics. The events result in: doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient underwent covid test post-vaccination on 27Apr2021 And on 12Apr2021, both via nasal swab and with negative results. Outcome of the events was not recovered. This report is reported as non-serious.
Head & Fever Narrative:  Employee developed a fever of approximately 101.3 at 12MN 1/7/2021 after receiving 2nd dose of vaccine on 1/6/2021. She states that she also suffered from a headache this morning.
Presents to hospital on 12/27 for 2 days history of worsening shortness of breath, fatigues, decreased appetite  CRP 2.05
Initial report received from a nurse on 23 Jun 2010: This patient was vaccinated with MENVEO (batch number: 091001) unknown dose, intramuscularly on 27 May 2010. The patient was only administered the diluent portion of MENVEO, rather than being reconstituted with the lyophilized portion. However, the patient received a full reconstituted dose of MENVEO on 28 May 2010. No adverse event occurred.
Shingrix given to a patient with active shingles; This case was reported by a pharmacist via call center representative and described the occurrence of drug use for unapproved indication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included shingles.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug use for unapproved indication. On an unknown date, the outcome of the drug use for unapproved indication was unknown.   Additional Information: GSK receipt date: 10-Aug-2022 Reporter's comment: The pharmacist stated that the first dose of Shingrix was given to a patient with active shingles. The reporter declined to provide contact details and rushed off the phone before specialist could attempt to collect further details.  No further information available. The reporter did not consent to follow-up. Additional supportive information: The patient received a dose of Shingrix with active shingles, which led to drug use for unapproved indication.
Erythema of 4-5cm, + itching, induration at site of 3 cm. No abscess.
This spontaneous report as received from an office manager refers to a 12 month old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 24-JUN-2015, the patient was accidentally vaccinated with a dose of VARIVAX (Merck) (subcutaneously; dose, lot # and expiration date were not reported). No adverse effects were reported. The office manager also stated that a vial of VARIVAX (Merck) with the flip cap dislodged and was found inside carton. The outcome of the adverse event was unknown. The relatedness between the adverse event and the vaccination with VARIVAX (Merck) was not reported. A product quality complaint (PQC) was filed. Additional information has been requested.
after 1st vaccine he noted slowed heart rate and irregular heart rate. Also developed dizziness/lightheadedness. These symptoms worsened after 2nd vaccine (received on 2/3/21.) PCP in community did Holter that confirmed heart block. He presented to clinic today.
Pain at the injection site, Wrong injection site....given way below the deltoid, right above the elbow joint, swollen sharp pain running down through my left arm. Treatments: ultra sounds and vascular ultra sounds. Referred to occupational therapy, TYLENOL tablet, NAPROXEN for pain, warm and cold compressions.
Fever 103 , chills, diaphoresis, tachycardia, cellulitis shoulder, chest, arm and neck, dehydration, elevated liver function tests.  Person giving vaccine said "Oops, I am sorry", but patient not sure what happened. Discharge summary states hepatitis, pleural effusion. msv Follow-up: ? MRSA infection.
fever 101, body aches, chills, profuse sweating  headache, abdominal cramping call sick 1/19 and 1/20
9/24 - shot 1:15pm, 5:00pm wheezing tightness of chest, cough, 5:30pm chills, 6:00pm passed out (fainting) standing, 6:30pm fever 102 degrees, 7pm took TYLENOL, 9pm took BENADRYL PM 9/25 - 6:30AM Fever 100 degrees. Sunday (9/26) - 3in redness at site
On 3/7/00, the pt developed a generalized vesicular rash. The pt's mother reported that on 3/6/00 the pt had a little fever and an unknown number of vesicles. The pt sought unspecified medical attention.
In late May I got a very sore throat and lost my voice and then 2 weeks later tested positive for Covid
sleepy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101834543.  A 53-year-old patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunization; pregabalin (LYRICA) (Batch/Lot number: unknown).   The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: SOMNOLENCE (non-serious), outcome "unknown", described as "sleepy". The action taken for pregabalin was dosage reduced.  Additional information: The patient's doctor changed everything from 150 to 100 and he changed the doses because it made patient sleepy.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Redness at injection site, and a red rash underneath that is warm to the touch and covers 1/3 of my upper arm. Also slight nausea and fever. Acetaminophen, and ice packs. So far, they're not helping.
pt recv vax;fever of 101 for 2 days;to er;tx w/ motrin & apap;to md;dx of fluid behind ears & started on biaxin;
Fully vaccinated patient tested positive for COVID-19 on 7/30/31. Symptoms included headache, congestion, malaise.
Bilateral Pulmonary Embolism: Symptoms began acutely at 8pm on 4/12/2021. She developed chest pain,  shortness of breath and nausea. Sharp pain. She was seen in the emergency department and at that time D-dimer was elevated to 1338. She had a subsequent CT scan that showed Subsegmental pulmonary emboli in posterior basal segments of lower lobe bilaterally
On 12/22/2022 in the morning I had a doctor's appointment at 08:30am since I had blood work done my doctor wanted to discuss the results. My doctor told me that my platelet count was high so, he do another follow-up appointment on 04/01/2023 at 08:30am requesting blood work again to verify the issue my platelet count. He said after the blood tests results we can decide from there about treatments. I feel normal but its just concerning what caused my platelet count to be so high. I received other COVID-19 vaccinations but nothing happened except for a sore arm each time.
pt recv ax 29JAN96 & 9APR96 titer was negative for rubella antibodies;the reporter noted that pt records were no longer accessible to office;
Numb and swollen upper lip, headache, brain fog, numbness down both arms to elbow, and extreme fatigue. Also back of tongue swollen and numb.
pt devel hives w/severe itching p/MMR & HIB immun given 23APR94;had hives head to toe w/patches being worse on legs & hips areas; devel fever of up to 103 allergic react to MMR;devel fever of up to 103 by 28PAR-30APR;ear infect, runny nose
patient got sick with flu shot; Initial information was received on 24-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer via social media.  This case involves a female patient of unknown age who got sick (illness), while she received vaccine INFLUENZA VACCINE.  The patient's past vaccination(s) included Influenza vaccine as Influenza vaccine. The patient's medical history, past medical treatment(s), concomitant therapy, and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient got sick (illness) (Unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.   It was not reported if the patient received any corrective treatment.  On an unknown date, outcome of the event was unknown.  There will be no information available on batch number for this case.
've had them 5 times. Had the shot several years ago and it didn't help/suspected vaccination failure; shingles; seems to keep the pain away; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine and Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and pain were recovering/resolving.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had them 5 times and had the shot several years ago and it did not help, refer case US2021AMR191936. The patient had the new shot and improved that which the patient had a reaction to. The patient said the best thing was, the patient had found to use when you first feel shingles starting was to put blue kote on them. It seems to keep the pain away and helps them heal quicker, blue kote worked for the patient. No contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR191936:same patient same reporter
Bells Palsy; This is a spontaneous report from a contactable physician. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date unknown), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was diagnosed with Bells Palsy after first dose of vaccine on an unspecified date. The outcome of the event was unknown.  Information on the batch/lot number has been requested.; Sender's Comments: A causal relationship between the event Bells Palsy and suspect product BNT162B2 is possible based on the information provided, drug profile and a temporal association. This case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
About 5 minutes after vaccination the patients body became stiff for about a minute, also went pale and lips turned white.  Had patient lie down and rest for about 10-15 minutes.  He also ate a protein bar.  Color in face/lips returned to normal.  Had patient remain in pharmacy for another 15 minutes for further observation, no other adverse effects.  Although the patient stated never having an adverse effect to any other vaccines on the pre-vaccination questionaire; after recovering he asked "did I go stiff?", when told yes he said "that happened once before when I had a vaccine".
died as a result of the COVID-19 vaccine shot; This is a spontaneous report from a contactable consumer reporting same event under the same suspect product for twenty patients.   A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The reporter personally knows of 20 people who have died as a result of the COVID-19 vaccine shot. The patient died on an unspecified date. It was not reported if an autopsy was performed.  The lot number for BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : PFIZER INC-202101393431 same reporter, product/event; different patient; Reported Cause(s) of Death: died as a result of the COVID-19 vaccine shot
HCP called regarding ROTATEQ. Product was administered to three different patients post TE.. Patient has not reported signs/symptoms of adverse effects.; HCP called regarding ROTATEQ. Product was administered to three different patients post TE.. Patient has not reported signs/symptoms of adverse effects.; This spontaneous report has been received from a nurse regarding a female patient.  The patient's medical history and concomitant therapies were not reported.   On an unspecified date, the patient received  rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # 1968382, expration date 21-MAY-2024 (strength, dose were not provided). It was reported that the vaccine was administered post-temperature excursion (TE) (Improper storage of product in use), but the patient did not report any adverse event.  This is one of several reports received from the same reporter.
Myocarditis; chest pain, troponin leak, peaked at 0.12. Improved w/ Maalox and Famotidine, essentially self-limited.
very dizziness; arm is swollen up (L arm, injection site); chills like a flu; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (very dizziness), VACCINATION SITE SWELLING (arm is swollen up (L arm, injection site)) and CHILLS (chills like a flu) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes mellitus.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (very dizziness), VACCINATION SITE SWELLING (arm is swollen up (L arm, injection site)) and CHILLS (chills like a flu). At the time of the report, DIZZINESS (very dizziness), VACCINATION SITE SWELLING (arm is swollen up (L arm, injection site)) and CHILLS (chills like a flu) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitantly, patient was taking medication for diabetes type 2. No treatment related information has been reported.   Reporter did not allow further contact
EXTREME HEART PALPATATIONS X 4 DAYS, TWITCHING AT NIGHT X 4 DAYS, RACING/POUNDING HEAR X 4DAYS, FAINTING FEELING, RIGHT ARM PAIN FOR ONE NIGHT THIS IS VERY EXTREME AND FEELS LIKE IM GOING TO HAVE A HEART ATTACK. NONE OF THIS WAS HAPPENING UNTIL I WAS VACCINATED.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 69-year-old male patient received BNT162b2 (BNT162B2), on 05Feb2021 at 12:00 as dose 1, single (Batch/Lot number: unknown), in right arm, on 28Feb2021 at 03:00 as dose 2, single (Batch/Lot number: unknown), in right arm, on 12Oct2021 at 12:00 as dose 3 (booster), single (Batch/Lot number: unknown), in right arm and on 16May2022 at 09:30 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 69 years, in right arm for Covid-19 immunisation. The patient's relevant medical history included: "diabetes" (unspecified if ongoing); "Heart attack", start date: 2019 (unspecified if ongoing). Concomitant medication(s) included: ALLOPURINOL, start date: Mar2009; METFORMIN, start date: May2014. Past drug history included: No, reaction(s): "Allergy". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 29May2022 at 08:00, outcome "not recovered" and all described as "COVID-19 treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Negative, notes: I was symptoms free and tested negative; (29May2022) Positive. Therapeutic measures were not taken as a result of vaccination failure, Covid-19. Clinical course: Adverse event: Patient taken Statin from unknown date in Nov2019 to 20May2022. On day 8 after starting Paxlovid I was symptoms free and tested negative. On day 10, today 29May2022 I developed a sore throat and tested positive. Other medication in 2 weeks: Yes Anti-viral details: product: COVID-19 Treatment, Brand: Paxlovid Treatment start date: 20May2022, Treatment start date: 25May2022, Indication: Treatment of COVID-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history or concurrent conditions was provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 injection (lot# L023230, expiry date 28-JUL-2017 and lot# L016428, expiry date 30-JUL-2017; dose and route of administration were not reported). There were no concomitant therapies reported. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Patient left the clinic with parents 5 minutes after receiving vaccination.  his parents brought him back 7 minutes later because he became lethargic and pale. He was brought into the exam room and placed in supine position. Vital signs were normal. Within 3 minutes his eyes brightened, and lips became bright pink. He was able to converse with examiner and reported he was feeling better. he then sat up and was given juice to drink. He left the clinic 10 minutes after arrival in stable condition and back to his normal level of activity.
approx 3yrs p/vax pt exp herpes zoster. devel 1 lesions on stomach then devel herpes zoster.
A week or less later patient got red bumps all over his body he had a fever throwing up and diarrhea.